Group I mGluR-induced epileptogenesis: distinct and overlapping roles of mGluR1 and mGluR5 and implications for antiepileptic drug design
- PMID: 16059439
- PMCID: PMC1176311
- DOI: 10.1111/j.1535-7597.2005.05207.x
Group I mGluR-induced epileptogenesis: distinct and overlapping roles of mGluR1 and mGluR5 and implications for antiepileptic drug design
Abstract
The group I metabotropic glutamate receptor subtypes, mGluR1 and mGluR5, have both distinct and overlapping actions in epileptogenesis. Data are reviewed revealing how activation of these receptor subtypes participates in the induction and maintenance of the long-lasting epileptiform discharges elicited in the hippocampal circuit. Differences in the cellular actions and regional distributions of mGluR1 and mGluR5 provide hints regarding the potential usefulness and limitations of subtype-specific antagonists as antiepileptic agents.
Similar articles
-
Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts.J Neurophysiol. 2002 Jan;87(1):621-5. doi: 10.1152/jn.00579.2001. J Neurophysiol. 2002. PMID: 11784776
-
Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices.J Neurophysiol. 2002 Oct;88(4):1625-33. doi: 10.1152/jn.2002.88.4.1625. J Neurophysiol. 2002. PMID: 12364493
-
Differential roles for group 1 mGluR subtypes in induction and expression of chemically induced hippocampal long-term depression.J Neurophysiol. 2006 Apr;95(4):2427-38. doi: 10.1152/jn.00383.2005. Epub 2006 Jan 18. J Neurophysiol. 2006. PMID: 16421200
-
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.CNS Drug Rev. 2006 Summer;12(2):149-66. doi: 10.1111/j.1527-3458.2006.00149.x. CNS Drug Rev. 2006. PMID: 16958988 Free PMC article. Review.
-
Role of metabotropic glutamate receptors in the control of neuroendocrine function.Neuropharmacology. 2008 Sep;55(4):577-83. doi: 10.1016/j.neuropharm.2008.06.022. Epub 2008 Jun 20. Neuropharmacology. 2008. PMID: 18616955 Review.
Cited by
-
Targeting glutamate synapses in schizophrenia.Trends Mol Med. 2011 Dec;17(12):689-98. doi: 10.1016/j.molmed.2011.08.004. Epub 2011 Sep 28. Trends Mol Med. 2011. PMID: 21955406 Free PMC article. Review.
-
Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors.Front Mol Neurosci. 2018 Aug 29;11:307. doi: 10.3389/fnmol.2018.00307. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30210294 Free PMC article. Review.
-
Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.Curr Opin Pharmacol. 2015 Feb;20:40-5. doi: 10.1016/j.coph.2014.11.003. Epub 2014 Nov 27. Curr Opin Pharmacol. 2015. PMID: 25462291 Free PMC article. Review.
-
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning.Neuropsychopharmacology. 2009 Aug;34(9):2057-71. doi: 10.1038/npp.2009.30. Epub 2009 Mar 18. Neuropsychopharmacology. 2009. PMID: 19295507 Free PMC article.
-
Beyond dopamine: glutamate as a target for future antipsychotics.ISRN Pharmacol. 2012;2012:427267. doi: 10.5402/2012/427267. Epub 2012 Jul 5. ISRN Pharmacol. 2012. PMID: 22830044 Free PMC article.
References
-
- Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. 1997;37:205–237. - PubMed
-
- Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev. 1999;29:83–120. - PubMed
-
- Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130:1007S–1015S. - PubMed
-
- De Blasi A, Conn PJ, Pin J, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci. 2001;22:114–120. - PubMed
-
- Conn PJ. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci. 2003;1003:12–21. - PubMed
LinkOut - more resources
Full Text Sources